NEW YORK, Aug. 27, 2015 /PRNewswire/ -- Virtus ETF Solutions announced today that the net asset value ("NAV") reported on August 25 was incorrect due to a technical malfunction experienced by the fund accounting agent, which calculates the NAV. The correct NAVs are provided below. NAV per share does not represent the market price at which an investor may trade shares of the fund on the NYSE or the NASDAQ. The closing market price on that date remains unchanged.
|
ETF Ticker
|
ETF Name
|
Originally Published NAV Per Share ($)
|
Adjusted NAV Per Share ($)
|
Difference ($)
|
Difference (%)
|
|
AMZA
|
InfraCap MLP ETF
|
14.41
|
15.58
|
1.16
|
8.08%
|
|
TUTT
|
Tuttle Tactical Management U.S. Core ETF
|
22.61
|
22.02
|
-0.59
|
-2.62%
|
|
BBC
|
BioShares Biotechnology Clinical Trials Fund
|
29.99
|
29.23
|
-0.75
|
-2.51%
|
|
NFLT
|
Newfleet Multi-Sector Unconstrained Bond ETF
|
25.00
|
24.99
|
-0.01
|
-0.02%
|
|
BBP
|
BioShares Biotechnology Products Fund
|
31.35
|
30.39
|
-0.95
|
-3.04%
|
|
TUTI
|
Tuttle Tactical Management Multi-Strategy Income ETF
|
23.71
|
23.60
|
-0.11
|
-0.45%
|
About Virtus ETF Solutions
Virtus ETF Solutions, formerly ETF Issuer Solutions, an affiliate of Virtus Investment Partners, operates a multi-manager ETF platform, providing investors access to differentiated investment capabilities from select subadvisers.
Logo - http://photos.prnewswire.com/prnh/20121031/NE03346LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/virtus-etf-solutions-announces-revised-net-asset-value-information-for-listed-etfs-300134178.html
SOURCE Virtus ETF Solutions
